Kogo, Mariko
Sato, Susumu
Muro, Shigeo
Matsumoto, Hisako
Nomura, Natsuko
Tashima, Noriyuki
Oguma, Tsuyoshi
Sunadome, Hironobu
Nagasaki, Tadao
Murase, Kimihiko
Kawaguchi, Takahisa
Tabara, Yasuharu
Matsuda, Fumihiko
Chin, Kazuo
Hirai, Toyohiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (25293141, 26670313, 26293198, 17H04182, 17H04126, 17H04123, 18K18450)
Japan Agency for Medical Research and Development (dk0207006, dk0207027, ek0109070, ek0109283, ek0109196, ek0109348, kk0205008, ek0210066, ek0210096, ek0210116, le0110005)
Ministry of Health, Labour and Welfare (H29-intractable diseases-general-027, H29-intractable diseases-general-027)
Takeda Medical Research Foundation
Mitsubishi Foundation
Daiwa Securities Health Foundation
Sumitomo Foundation
Research Foundation for Healthy Ageing
Research on Region Medical (H28-iryo-ippan-016, H30-iryo-ippan-009, H28-iryo-ippan-016, H30-iryo-ippan-009)
Health, Labour and Welfare Sciences Research Grants
Article History
Received: 27 March 2022
Accepted: 18 November 2022
First Online: 21 November 2022
Competing interests
: M. K, S. M, H. M, N. N, N. T, T. O, T.K, and T. H have nothing to disclose. S. S reports a grant from Nippon Boehringer Ingelheim Co. and grants from Philips-Respironics, Fukuda Denshi, Fukuda Lifetec Keiji, and ResMed that did not pertain to the submitted work. H. S, and T. N, report grants from Philips-Respironics, Fukuda Denshi, Fukuda Lifetec Keiji, ResMed. K. M reports grants from Philips-Respironics, Teijin Pharma, Fukuda Denshi, Fukuda Lifetec Keiji, ResMed and Japan Society for the Promotion of Science, none of which pertained to the submitted work. Y. T reports grants from the Japan Agency for Medical Research and Development (AMED) and The Ministry of Education, Culture, Sports, Science and Technology in Japan during the study period. K. C reports grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology; grants from the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, the Ministry of Health, Labour and Welfare, Japan; grants from the Research Foundation for Healthy Ageing; grants from Health, Labour and Welfare Sciences Research Grants, Research on Region Medical; grants from the Center of Innovation Program and the Global University Project from Japan Science and Technology Agency, Japan Agency for Medical Research and Development during the study period; grants and personal fees from Philips-Respironics, Teijin Pharma, Fukuda Denshi, Fukuda Lifetec Tokyo, Fukuda Lifetec Keiji, GlaxoSmithKline and Resmed; grants from KYORIN Pharmaceutical Co., Ltd. and Nippon Boehringer Ingelheim Co., Ltd; personal fees from MSD, Astellas Pharma and Eisai Co., Ltd; none of these pertained to the submitted work. F. M reports grants from Kyoto University, the Ministry of Education, Culture, Sports, Science and Technology in Japan, Japan Agency for Medical Research and Development (AMED) and The Takeda Medical Research Foundation during the study period.